Annual Current Assets
$667.80 M
-$70.16 M-9.51%
31 December 2023
Summary:
Intra-Cellular Therapies annual total current assets is currently $667.80 million, with the most recent change of -$70.16 million (-9.51%) on 31 December 2023. During the last 3 years, it has fallen by -$23.11 million (-3.34%). ITCI annual current assets is now -9.51% below its all-time high of $737.96 million, reached on 31 December 2022.ITCI Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$1.27 B
+$7.48 M+0.59%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly total current assets is currently $1.27 billion, with the most recent change of +$7.48 million (+0.59%) on 30 September 2024. Over the past year, it has increased by +$569.31 million (+81.05%). ITCI quarterly current assets is now at all-time high.ITCI Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.5% | +81.0% |
| 3 y3 years | -3.3% | +138.5% |
| 5 y5 years | +87.9% | +390.1% |
ITCI Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.5% | +42.9% | at high | +172.2% |
| 5 y | 5 years | -9.5% | +189.9% | at high | +452.1% |
| alltime | all time | -9.5% | >+9999.0% | at high |
Intra-Cellular Therapies Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.27 B(+0.6%) |
| June 2024 | - | $1.26 B(+83.1%) |
| Mar 2024 | - | $690.53 M(+3.4%) |
| Dec 2023 | $60.50 M(+259.6%) | $667.80 M(-4.9%) |
| Sept 2023 | - | $702.42 M(+0.6%) |
| June 2023 | - | $698.07 M(-1.1%) |
| Mar 2023 | - | $706.09 M(-4.3%) |
| Dec 2022 | $16.82 M(-25.7%) | $737.96 M(-2.9%) |
| Sept 2022 | - | $759.76 M(-3.7%) |
| June 2022 | - | $789.21 M(-7.0%) |
| Mar 2022 | - | $848.34 M(+81.5%) |
| Dec 2021 | $22.64 M(-14.3%) | $467.28 M(-12.4%) |
| Sept 2021 | - | $533.24 M(-11.3%) |
| June 2021 | - | $601.30 M(-7.4%) |
| Mar 2021 | - | $649.10 M(-6.1%) |
| Dec 2020 | $26.41 M(+26.6%) | $690.90 M(-7.2%) |
| Sept 2020 | - | $744.87 M(+78.0%) |
| June 2020 | - | $418.57 M(-9.2%) |
| Mar 2020 | - | $460.97 M(+100.1%) |
| Dec 2019 | $20.86 M(+1080.1%) | $230.32 M(-11.2%) |
| Sept 2019 | - | $259.46 M(-10.0%) |
| June 2019 | - | $288.34 M(-10.2%) |
| Mar 2019 | - | $321.13 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $1.77 M(-22.2%) | $355.44 M(-7.3%) |
| Sept 2018 | - | $383.25 M(-6.4%) |
| June 2018 | - | $409.66 M(-7.6%) |
| Mar 2018 | - | $443.15 M(-5.6%) |
| Dec 2017 | $2.27 M(+222.9%) | $469.22 M(+40.7%) |
| Sept 2017 | - | $333.44 M(-4.4%) |
| June 2017 | - | $348.83 M(-6.1%) |
| Mar 2017 | - | $371.61 M(-4.3%) |
| Dec 2016 | $703.40 K(-17.0%) | $388.20 M(-28.4%) |
| Sept 2016 | - | $541.82 M(+21.3%) |
| June 2016 | - | $446.81 M(-3.5%) |
| Mar 2016 | - | $462.86 M(-4.2%) |
| Dec 2015 | $847.40 K(+575.2%) | $483.26 M(-5.7%) |
| Sept 2015 | - | $512.26 M(+140.9%) |
| June 2015 | - | $212.61 M(-10.1%) |
| Mar 2015 | - | $236.50 M(+80.6%) |
| Dec 2014 | $125.50 K(-37.2%) | $130.99 M(-4.7%) |
| Sept 2014 | - | $137.48 M(-2.6%) |
| June 2014 | - | $141.21 M(-3.5%) |
| Mar 2014 | - | $146.37 M(+282.7%) |
| Dec 2013 | $199.80 K(>+9900.0%) | $38.25 M(-18.8%) |
| Sept 2013 | - | $47.13 M(>+9900.0%) |
| June 2013 | - | $0.00 |
| Mar 2013 | $0.00 | - |
FAQ
- What is Intra-Cellular Therapies annual total current assets?
- What is the all time high annual current assets for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual current assets year-on-year change?
- What is Intra-Cellular Therapies quarterly total current assets?
- What is the all time high quarterly current assets for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly current assets year-on-year change?
What is Intra-Cellular Therapies annual total current assets?
The current annual current assets of ITCI is $667.80 M
What is the all time high annual current assets for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual total current assets is $737.96 M
What is Intra-Cellular Therapies annual current assets year-on-year change?
Over the past year, ITCI annual total current assets has changed by -$70.16 M (-9.51%)
What is Intra-Cellular Therapies quarterly total current assets?
The current quarterly current assets of ITCI is $1.27 B
What is the all time high quarterly current assets for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly total current assets is $1.27 B
What is Intra-Cellular Therapies quarterly current assets year-on-year change?
Over the past year, ITCI quarterly total current assets has changed by +$569.31 M (+81.05%)